Gene Query: SLC4A2

Dataset Description Geneva Score
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 33.05
Genome wide miR-191 target profile determined by RIP and gene expression profiling 33.05
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 32.49
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 29.71
Genome wide expression change in LCC2 and MCF-7 cells 29.55
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 29.16
TGF-β regulation of miRNA expression in pancreatic cancer 27.76
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 27.11
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 26.93
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 25.05
Early response of human ovarian and fallopian tube surface epithelial cells to norepinephrine 24.91
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 24.88
Studying the selectivity of a small molecule Synucleozid on transcriptome 24.73
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 24.7
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 24.37
BAF controls genome accessibility 23.49
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 23.2
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 23.19
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 23.09
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 22.74
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 22.4
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 22.4
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 21.7
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 21.57
Mechanistic Model-Guided Study of Embryonic Morphogenesis 21.37
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 21.03
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 20.78
DART-seq: an antibody-free method for global m6A detection 20.75
RNA-seq analyses of human prostate cancer cells 19.65
EP400 is required for Max and MCPyV mediated gene activation 19.21
Nucleoporin-mediated regulation of cell identity genes 19.14
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 18.73
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 18.66
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 18.43
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 18.38
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 18.2
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 17.82
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 17.82
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 17.67
Gene expression changes caused by KRAS in MCF-10A 17.35
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 17.22
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 17.22
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 17.21
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 17.21
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 17.13
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 16.94
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 16.92
Targeting EZH2 in MYCN-amplified Neuroblastoma 16.92
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 16.88
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 16.87
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 16.82
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 16.76
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 16.73
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 16.54
MYCi975 regulates MYC target genes 16.43
RNA-seq of tumor cells following angiopellosis extravasation 16.32
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 16.2
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 16.02
The pause-initiation limit restricts transcription activation in human cells 15.92
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 15.51
Role of XRN2 ribonucleolytic activity in RNA metabolism 15.49
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 15.34
miR941 overexpression experiment 15.25
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 15.22
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 15.15
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 15.09
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 15.03
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 15.02
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 15.01
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 15.01
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 15.01
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 15.01
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 14.98
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 14.97
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 14.95
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 14.95
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 14.8
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 14.74
Expression level comparison under dividing and quiescent states in human primary fibroblasts 14.53
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 14.46
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 14.23
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 14.19
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 14.03
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 13.98
ROR-γ drives androgen-receptor expression and represents a therapeutic target in castration-resistant prostate cancer 13.87
Mitochondrial dsRNA triggers antiviral signalling in humans 13.84
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 13.77
Modeling Familial Cancer with iPSC Approaches 13.58
13.47
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 13.45
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 13.45
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 13.37
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 13.37
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 13.35
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 13.12
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 13.11
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 13.07
U1 snRNP telescripting regulates size-function stratified human genome 12.97
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 12.78
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 12.78
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 12.73
Searching for target genes of miR-508/509/506/514 in HCT116 cells 12.63
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 12.49
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 12.44
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 12.23
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 12.23
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 12.22
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 12.22
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 12.13
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 12.04
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 12.04
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 12.03
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 12.01
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 11.96
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 11.94
Gene induction by the USP6 oncogene in response to interferon 11.94
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 11.88
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 11.88
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 11.85
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 11.81
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 11.78
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 11.67
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 11.67
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 11.65
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 11.58
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  11.49
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 11.46
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 11.33
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 11.33
SNHG5 siRNA knock down in HCT116 cells 11.3
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 11.22
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 11.09
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 11.06
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 11.01
TCF7L1 knockdown in pancreatic cancer 10.97
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 10.96
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 10.93
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 10.71
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 10.64
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 10.63
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 10.56
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 10.41
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 10.38
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 10.34
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 10.34
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 10.11
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 10.09
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 10.09
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 10.04
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 10.0
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 9.98
Hepatitis C virus functionally sequesters miR-122 9.98
High-throughput sequencing of pluripotent cells 9.96
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 9.95
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 9.94
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 9.94
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 9.93
SRSF2 mutations impair hematopoiesis and alter exon recognition 9.92
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 9.89
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 9.87
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 9.83
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 9.82
LNCaP treated with iBET 9.78
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 9.73
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 9.72
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 9.72
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 9.68
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 9.68
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 9.66
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 9.65
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 9.63
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 9.62
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 9.59
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 9.54
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 9.53
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 9.53
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 9.52
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 9.47
Systematic discovery of endogenous human ribonucleoprotein complexes 9.44
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 9.4
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 9.37
Ribosomal footprinting of CN34-Parental and CN34-LM1a 9.27
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 9.22
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 9.22
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 9.16
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 9.13
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 9.13
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 9.12
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 9.12
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 9.1
DJ-1 is dispensable for human stem cell homeostasis 9.07
HNF1A deficiency impairs β-cell fate, granule maturation and function 9.02
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 8.99
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 8.97
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 8.97
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 8.93
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 8.9
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 8.87
RNA transcriptome analysis during HSV-1 infection 8.85
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 8.79
RIG-I and MDA5 fRIP during KSHV lytic reactivation 8.76
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 8.75
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 8.75
Identification of global regulators of T-helper cell lineage specification 8.69
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 8.69
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 8.67
RNA-seq melanoma 8.63
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 8.61
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 8.6
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 8.52
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 8.5
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 8.48
hTERT promotes cell adhesion and migration independent of telomerase activity 8.46
RNA-seq of MDA-MB-231 cells with TET1 knockout 8.31
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 8.26
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 8.24
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 8.22
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 8.11
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 8.1
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 8.06
RNA sequencing of BT142 and TS603 cell lines 8.06
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 8.05
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 8.04
mRNA expression in human DAOY cells 7.98
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 7.86
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 7.82
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 7.79
HBEC-shp53-PCHD7 7.75
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 7.74
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 7.67
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 7.66
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 7.61
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 7.58
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 7.54
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 7.54
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 7.48
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 7.47
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 7.44
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 7.42
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 7.42
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 7.41
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 7.38
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 7.35
The cytokine environment influence on human skin-derived T cells 7.31
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 7.29
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 7.22
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 7.22
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 7.17
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 7.17
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 7.12
Expression profiling of MCF-7 cells with treatment of TCDD 7.12
Biological effect of chronic mistranslation in mammalian cells 7.12
Splicing and epigenetic factors jointly regulate epidermal differentiation 7.05
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 6.97
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 6.96
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 6.93
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 6.91
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 6.91
RNA-sequencing in irradiated and normal A549 cells. 6.86
LncRNA expression profiling of ischemic stroke patients 6.85
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 6.85
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 6.84
Differential responses of human fetal brain neural stem cells to Zika virus infection 6.81
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 6.69
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 6.6
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 6.56
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 6.56
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 6.52
Sensing self and nonself circular RNAs 6.48
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 6.45
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 6.42
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 6.4
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 6.38
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 6.36
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 6.36
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 6.34
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 6.3
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 6.3
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 6.28
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 6.16
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 6.15
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 6.15
BET bromodomain inhibition 6.14
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 6.14
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  6.09
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 6.05
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 6.01
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 6.01
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 6.0
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 5.99
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 5.99
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 5.99
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 5.99
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 5.96
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 5.96
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 5.96
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 5.96
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 5.95
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 5.95
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 5.9
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 5.9
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 5.88
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 5.82
Effect of BB608 on Gene Expression in HNSCC Cell Line 5.8
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 5.78
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 5.77
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 5.74
circRNA-sequencing 5.73
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 5.62
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 5.62
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 5.59
RNA-Seq of the corpus callosum from 12 individuals 5.57
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 5.53
ADAR1-editing of cellular and measles virus-derived duplex RNA 5.52
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 5.52
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 5.49
Global analyses of the effect of different cellular contexts on microRNA targeting 5.39
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 5.39
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 5.37
RNA sequencing of human mammary epithelial cells 5.37
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 5.24
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 5.21
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 5.13
Regulation of poly(A) tail and translation during the somatic cell cycle 5.12
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 5.11
METTL3 and WTAP 5.1
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 5.09
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 5.08
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 5.01
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 4.94
Comparative Analysis of Cas9 Activators Across Multiple Species 4.91
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 4.89
Illumina Total RNA-seq in HeLa 4.88
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 4.77
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 4.77
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 4.71
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 4.65
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 4.65
NAPRT activation of macrophages 4.6
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 4.58
A prostate cancer chromatin interaction map 4.58
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 4.58
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 4.58
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 4.57
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 4.52
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 4.52
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 4.47
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 4.47
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 4.44
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 4.43
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 4.43
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.41
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 4.41
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 4.4
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 4.37
RNA Sequencing of three pairs of gastric cancer 4.28
RNA-seq of cells with TET1 knockout 4.26
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 4.23
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 4.23
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 4.2
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 4.19
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 4.1
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 4.06
Toxoplasma gondii infection of human retinal pigment epithelial cells 4.05
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 4.03
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 4.03
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 4.03
The Glioma-Infiltrating T Cell Receptor Repertoire 3.91
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 3.84
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 3.78
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 3.78
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 3.76
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 3.66
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 3.64
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 3.63
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.58
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 3.55
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 3.53
ChIP-seq and RNA-seq from human lymphoma cell lines 3.51
RNA-seq data from human lymphoma cell lines 3.51
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.48
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 3.46
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 3.43
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 3.32
RNA-seq differential expression studies: more sequence, or more replication? 3.21
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 3.2
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 3.2
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 3.18
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 3.13
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.1
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 3.08
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 3.08
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 3.08
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.07
DAOY-Notch1/Notch2 knockout: transcriptome comparison 3.06
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 3.02
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 2.98
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 2.98
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 2.96
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 2.87
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 2.87
Gene expression changes due to PARP knockdown in human cells 2.77
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.74
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 2.68
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 2.68
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.66
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.66
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 2.62
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 2.53
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 2.49
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 2.42
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 2.4
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 2.38
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 2.34
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 2.32
Illumina Human Polycystic Liver Disease and Normal Biliary Stem Cell RNAseq 2.3
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 2.26
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 2.25
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 2.22
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.21
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 2.2
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 2.17
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.15
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 2.09
RNA-Seq in PWS iPSC-derived neurons 2.07
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.07
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 2.02
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 2.02
Ribosome profiling upon inhibition of eIF4A 2.01
Solid phase chemistry to covalently and reversibly capture thiolated RNA 1.99
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 1.96
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 1.96
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.96
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 1.93
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 1.92
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 1.92
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 1.82
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 1.81
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.81
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 1.81
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 1.78
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 1.78
Tracing Enhancer Networks using Epigenetic Traits (TENET) 1.75
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.62
Interaction between mitoNEET and NAF-1 in cancer cells 1.6
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.51
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.45
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.44
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.4
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.4
SRSF1 role in cellular gene expression and splicing 1.39
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.32
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.32
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 1.32
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.28
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.24
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.12
Transposon-based construction of strand-specific RNA-seq libraries 1.11
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 1.02
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.0
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 0.98
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 0.97
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 0.97
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.96
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.81
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.78
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 0.76
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.76
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.57
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.55
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.54
The pioneer factor CEBPA modulates vitamin D signaling 0.54
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.52
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 0.47
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.45
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.42
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.38
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.38
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.37
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.36
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.36
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.34
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.32
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.32
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.27
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 0.25
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 0.24
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.22
Transcriptome analysis upon C6orf203 silencing 0.2
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.2
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.19
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.19
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 0.19
Widespread regulated alternative splicing of single codons accelerates proteome evolution 0.15
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.14
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.12
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.1
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 0.08
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.07
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation